Key Takeaways JNJ shares are up 16.7% in three months as momentum builds across its key businessesSector recovery and JNJ's plan to boost U.S. manufacturing support optimism around the stock.Pipeline progress and MedTech improvements underpin expectations for stronger growth ahead.Johnson & Johnson’s (JNJ) stock has risen 16.7% in the past three months. A lot of this price increase is due to strong third-quarter 2025 results, where in both the top and bottom lines exceeded expectations. J&J also raised its ...